Cognition Therapeutics, Inc. (CGTX)
0.8174
-0.02
(-2.42%)
USD |
NASDAQ |
Apr 07, 16:00
0.82
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics EPS Diluted (Quarterly) : -0.0376 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Equillium, Inc. | -0.0411 |
| Terns Pharmaceuticals, Inc. | -0.2395 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.343M |
| Total Expenses (Quarterly) | 3.343M |
| Enterprise Value | 36.68M |
| Earnings Yield | -43.74% |
| Normalized Earnings Yield | -43.74 |